Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients-Reference-Cited by-同舟云学术

Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients

Published:2021-07-30 Issue:30 Volume:100 Page:e26772
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Chen Xiaochen,Wang Jianxiang,Wang Sanbin,Jin Jie,Li Junmin,Gao Sujun,Li Jianyong,Li Juan,Liu Qifa,Hu Yu,Lin Dongjun,Sun Zimin,Yang Jianmin,Hu Jianda,Wu Xiaoxiong,Huang Xiaojun,Shao Zonghong,Deng Qi,Wang Chun,Liu Li,Chen Hu,Wang Jingbo,Wei Xudong,Shen Jianping,Zhang Xi,Wu Depei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference29 articles.

1. Factors associated with mortality in transplant patients with invasive aspergillosis;Baddley;Clin Infect Dis,2010

2. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database;Kontoyiannis;Clin Infect Dis,2010

3. Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies;Dwivedi;Exp Hematol,2017

4. Neutrophil extracellular traps in fungal infection;Urban;Semin Cell Dev Biol,2019

5. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients;Buess;BMC Infect Dis,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the clinical development of antifungal vaccines: a narrative review;Frontiers in Tropical Diseases;2024-08-08

2. Establishment of a risk classifier to predict the in-hospital death risk of nosocomial fungal infections in cancer patients;BMC Infectious Diseases;2023-07-17

3. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections;BMC Infectious Diseases;2023-05-25

4. Establishment of a risk classifier to predict the in-hospital death risk of nosocomial infections caused by fungi in cancer patients;2023-01-19

5. Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections;Expert Opinion on Pharmacotherapy;2021-11-10